ATE410150T1 - Neue weichgelatinekapseln - Google Patents

Neue weichgelatinekapseln

Info

Publication number
ATE410150T1
ATE410150T1 AT06708736T AT06708736T ATE410150T1 AT E410150 T1 ATE410150 T1 AT E410150T1 AT 06708736 T AT06708736 T AT 06708736T AT 06708736 T AT06708736 T AT 06708736T AT E410150 T1 ATE410150 T1 AT E410150T1
Authority
AT
Austria
Prior art keywords
soft gelatin
gelatin capsules
new soft
cyclodextrin
new
Prior art date
Application number
AT06708736T
Other languages
English (en)
Inventor
Giorgio Zoppetti
Maurizio Marchiorri
Original Assignee
Altergon Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altergon Sa filed Critical Altergon Sa
Application granted granted Critical
Publication of ATE410150T1 publication Critical patent/ATE410150T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT06708736T 2005-03-11 2006-03-13 Neue weichgelatinekapseln ATE410150T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000387A ITMI20050387A1 (it) 2005-03-11 2005-03-11 Nuove capsule di gelatina molle

Publications (1)

Publication Number Publication Date
ATE410150T1 true ATE410150T1 (de) 2008-10-15

Family

ID=35207489

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06708736T ATE410150T1 (de) 2005-03-11 2006-03-13 Neue weichgelatinekapseln

Country Status (12)

Country Link
US (2) US8728519B2 (de)
EP (1) EP1858494B1 (de)
KR (1) KR101342486B1 (de)
CN (1) CN101141952B (de)
AT (1) ATE410150T1 (de)
CA (1) CA2600969C (de)
DE (1) DE602006003073D1 (de)
DK (1) DK1858494T3 (de)
ES (1) ES2314884T3 (de)
IT (1) ITMI20050387A1 (de)
PT (1) PT1858494E (de)
WO (1) WO2006095026A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20061672A1 (it) * 2006-09-01 2008-03-02 Altergon Sa Formulazioni di acido acetilsalicilico o suoi derivati in capsule molli,esibenti elevata stabilita'
US8287904B2 (en) * 2010-08-19 2012-10-16 Lionel Borkan Stable soft capsule dosage form for acetylsalicylic acid
CN104311887A (zh) * 2014-09-19 2015-01-28 江苏崇尚生物科技有限公司 制备淀粉基质空心胶囊的原料组合物及淀粉基质空心胶囊
KR101550322B1 (ko) 2015-02-27 2015-09-04 김재훈 연질 캡슐 조성물
WO2017095736A1 (en) * 2015-12-01 2017-06-08 R.P. Scherer Technologies, Llc Aspirin soft gelatin capsule as a single active or in combination with other actives
CN106074434B (zh) * 2016-07-06 2019-01-18 中国科学院化学研究所 一种制备淀粉基质空心胶囊的原料组合物及空心胶囊
IT201700015145A1 (it) 2017-02-10 2018-08-10 Altergon Sa Capsule di gelatina molle ad elevata stabilità
IT201900013557A1 (it) * 2019-07-31 2021-01-31 Univ Degli Studi Di Sassari Gelatine animali modificate con ciclodestrine, procedimento per la loro preparazione, pellicole ottenute dalle stesse e loro uso nel campo dell’imballaggio

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62249935A (ja) 1986-04-18 1987-10-30 Toyo Kapuseru Kk サイクロデキストリンを含有する製剤用のゼラチン基質
JP4294862B2 (ja) * 1997-12-26 2009-07-15 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー ゼラチン組成物
US20030104048A1 (en) * 1999-02-26 2003-06-05 Lipocine, Inc. Pharmaceutical dosage forms for highly hydrophilic materials
US6262086B1 (en) * 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form

Also Published As

Publication number Publication date
CA2600969C (en) 2013-07-02
WO2006095026A2 (en) 2006-09-14
CA2600969A1 (en) 2006-09-14
CN101141952A (zh) 2008-03-12
EP1858494B1 (de) 2008-10-08
US9168229B2 (en) 2015-10-27
ES2314884T3 (es) 2009-03-16
WO2006095026A3 (en) 2007-01-11
KR101342486B1 (ko) 2013-12-19
DE602006003073D1 (de) 2008-11-20
DK1858494T3 (da) 2009-02-02
KR20070112252A (ko) 2007-11-22
EP1858494A2 (de) 2007-11-28
WO2006095026A8 (en) 2007-12-13
ITMI20050387A1 (it) 2006-09-12
PT1858494E (pt) 2009-01-14
US8728519B2 (en) 2014-05-20
US20140242161A1 (en) 2014-08-28
CN101141952B (zh) 2011-12-28
US20080206323A1 (en) 2008-08-28

Similar Documents

Publication Publication Date Title
IL205488A (en) Pharmaceutical or nutraceutical preparations comprising a core containing an active substance, an inner layer surrounding the core and an outer layer, a tablet, a gelatin or hpmc capsule comprising them and preparation thereof
CY1109690T1 (el) Ευθραυστη καψουλα τζελαν χωρις συγκολληση και διαδικασια για την κατασκευη αυτης
WO2007143652A3 (en) Chewable soft gelatin capsules
EA200801926A1 (ru) Таблетки парацетамола с быстрым высвобождением
MY157189A (en) Capsule formulation
ATE543489T1 (de) Orale dosierformen mit progesteron und verwendungs- und herstellungsverfahren dafür
NO20071044L (no) Doseformer med enteraltbelagte tablettkjerner
RU2009148985A (ru) Стабилизированные аморфные формы иматиниба мезилата
WO2007075475A3 (en) Gastric reflux resistant dosage forms
DE602006003073D1 (de) Neue weichgelatinekapseln
ZA200701443B (en) Pharmaceutical composition in the form of a gastric-resident tablet containing an active principle
ATE361743T1 (de) Beschichtete minitabletten von venlafaxinhydrochlorid mit verlängerter freisetzung
MX2019004554A (es) Forma de dosis farmaceutica de capsula de gelatina blanda con goma guar modificada.
MX2007002898A (es) Tableta con liberacion gastrointestinal controlada en sitio y tiempo del ingrediente activo.
BRPI0615195A8 (pt) preparação farmacêutica, embalagem, e, métodos para tratar doença gastrintestinal, para fabricar uma cápsula e para testar dissolução de cápsulas de balsalazida.
UY30126A1 (es) Una nueva sal farmaceuticamente aceptable de 2-hidroxi-3-(5-(morfolin-4-ilmetil)-piridin-2-l)1h-indol-5-carbonitrilo, procedimientos para su preparacion, composiciones que la contienen yaplicaciones
WO2005107709A3 (en) Softgel encapsulated pharmaceutical compositions comprising concentrated active ingredients
PL1941263T3 (pl) Optyczna półilościowa 100% kontrola napełniania kapsułek farmaceutycznych na maszynach do napełniania kapsułek
PH12014502170B1 (en) Drug composition and soft capsule drug sealing the drug composition
MX2009006735A (es) Capsulas de gelatina que comprenden un acido.
GB0624498D0 (en) Pharmaceutical compositon containing a stable and clear solution of anti-inflammatory drug in soft gelatin capsule and process for producing the same
WO2011128631A3 (en) Vegetarian oral pharmaceutical and nutraceutical compositions
WO2008062449A3 (en) A novel pharmaceutical soft gel composition containing dexibuprofen and paracetamol
UA92344C2 (ru) Топичная композиция, содержащая рыбный желатин
UY27314A1 (es) Capsulas para inhalación

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1858494

Country of ref document: EP